Biogened S.A. (WSE:BGD)
28.00
+1.00 (3.70%)
At close: Mar 31, 2025
Biogened Revenue
In the year 2024, Biogened had annual revenue of 110.94M PLN with 16.09% growth. Biogened had revenue of 29.27M in the quarter ending December 31, 2024, with 14.56% growth.
Revenue
110.94M
Revenue Growth
+16.09%
P/S Ratio
0.62
Revenue / Employee
499.71K
Employees
222
Market Cap
68.78M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 110.94M | 15.38M | 16.09% |
Dec 31, 2023 | 95.56M | 15.94M | 20.02% |
Dec 31, 2022 | 79.62M | 14.30M | 21.89% |
Dec 31, 2021 | 65.32M | 16.99M | 35.15% |
Dec 31, 2020 | 48.33M | 1.70M | 3.64% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Powszechna Kasa Oszczednosci Bank Polski Spólka Akcyjna | 27.34B |
Orlen | 296.95B |
Santander Bank Polska | 16.07B |
Powszechny Zaklad Ubezpieczen | 60.92B |
Bank Polska Kasa Opieki | 14.72B |
Dino Polska | 29.27B |
ING Bank Slaski | 9.75B |
mBank | 11.62B |